Login below, or create an account for free.
Eli Lilly and Company has announced the expansion of an existing immuno-oncology collaboration with Merck, to add a new study of Lilly's LARTRUVO™ with KEYTRUDA® in patients with previously treated advanced or metastatic soft tissue sarcoma (STS). More
Researchers from QUT are seeking participation of Queensland and Victorian adults with terminal cancer and their family members in a study exploring medical decision-making by and for people with cancer. More
Stay up to date with the latest news including upcoming events, campaigns and announcements from Rare Cancers Australia.
Rare Cancers Australia hosts a vareity of events throughout the year in support of rare cancer awareness. Come along and support our work.
See all events.
Support Rare Cancers Australia by donating to a campaign, a fundraiser, or even by setting up your own fundraising page!
Find out more.
Rare Cancers Australia Ltd (RCA) is a charity whose purpose is to improve awareness, support and treatment of Australians with rare and less common (RLC) cancers. Every year there are over 42,000 diagnoses of RLC Cancers and around 24,000 deaths.